Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis

Published:2017-03-06 Issue:5 Volume:24 Page:703-712
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Håkansson I.¹,Tisell A.²³,Cassel P.⁴,Blennow K.⁵⁶,Zetterberg H.⁵⁶⁷,Lundberg P.²³⁸,Dahle C.¹⁴,Vrethem M.¹,Ernerudh J.⁴

Affiliation:

1. Department of Neurology and Department of Clinical and Experimental Medicine; Linköping University; Linköping Sweden

2. Radiation Physics; Department of Medical and Health Sciences; Linköping University; Linköping Sweden

3. Center for Medical Image Science and Visualization (CMIV); Linköping University; Linköping Sweden

4. Department of Clinical Immunology and Transfusion Medicine and Department of Clinical and Experimental Medicine; Linköping University; Linköping Sweden

5. Institute of Neuroscience and Physiology; Department of Psychiatry and Neurochemistry; The Sahlgrenska Academy at University of Gothenburg; Gothenburg Sweden

6. Clinical Neurochemistry Laboratory; Sahlgrenska University Hospital; Mölndal Sweden

7. Department of Molecular Neuroscience; UCL Institute of Neurology; Queen Square London UK

8. Radiology; Department of Medical and Health Sciences; Linköping University; Linköping Sweden

Funder

Vetenskapsrådet

Novartis

Torsten Söderbergs Stiftelse

Royal Academy of Sciences, Sweden

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.13274/fullpdf

Reference31 articles.

1. What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque;Hartel;Neurol Neurochir Pol,2016

2. Brain atrophy and lesion load predict long term disability in multiple sclerosis;Popescu;J Neurol Neurosurg Psychiatry,2013

3. Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients;Fitzner;Autoimmun Rev,2015

4. Biomarkers in multiple sclerosis;Housley;Clin Immunol,2015

5. Biomarkers of therapeutic response in multiple sclerosis: current status;Harris;Mol Diagn Ther,2014

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid neurofilament light chain in acute optic neuritis and its predictive ability of multiple sclerosis;Journal of Neurology;2024-07-25

2. The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis;Medicina;2024-06-26

3. Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients.;Multiple Sclerosis and Related Disorders;2024-02

4. Serum neurofilament light chains in assessing the course of multiple sclerosis;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2024

5. How Early Is Early Multiple Sclerosis?;Journal of Clinical Medicine;2023-12-29